Skip to main content
. 2018 Feb 1;22(4):2458–2468. doi: 10.1111/jcmm.13551

Figure 4.

Figure 4

ARID1A down‐regulation refers to a poor recurrence‐free survival (RFS) rates in breast cancer patients. (A) Kaplan‐Meier analysis for ARID1A expression under the condition of RFS probability in breast cancer patients using SurvExpress database. HR denotes hazard ratio. Insert, boxplot for the mRNA levels of ARID1A in high (green) and low (red)‐risk cohorts in A. (B) Kaplan‐Meier analysis for ARID1A expression under the condition of RFS probability in patients with breast cancer using K‐M Plotter database. (C) A global meta‐analysis of ARID1A expression using PrognoScan database. HR denotes hazard ratio. (D and E) Kaplan‐Meier analysis for ARID1A expression under the condition of RFS probability in unclassified breast invasive carcinoma (BRCA) patients (D) and clinical cohort with TNBCs (E) using TCGA database